Unlike Type 2 Diabetes, often correlated with lifestyle factors and choices (including weight management, diet and exercise), Type 1 Diabetes is an inherent condition that sufferers have little control over contracting.
1.25 million adults and children in the United States are currently living with Type 1 Diabetes, which is characterized as an autoimmune disorder, where the patient’s immune system destroys cells in the pancreas, leading to long-term damage and the inability to produce insulin properly, causing trouble controlling blood sugar.
The disease – especially when poorly controlled – can lead to major negative effects, ranging from gout and skin infections to cardiovascular and even brain damage.
Because Type 1 Diabetes is classified as an autoimmune system, and because CBD is known to help regulate and promote balance throughout various body systems, especially as autoimmune conditions are concerned, it’s logical to assume that it could be helpful in the regulation of Type 1 Diabetes.
While the research is still forthcoming, and traditional medications and insulin are still the trusted first line of defense for Type 1 Diabetes, studies on the way that CBD interacts with the pancreas have become more popular, and the early results are promising.
In one study, posted in Clinical Hemorheology and Microcirculation, CBD was found to ease the inflammation Type 1 Diabetes causes within the pancreas in mice. Furthermore, it showed a lower overall occurrence of the disorder, which could have positive ramifications for future human studies.
While CBD has not been proven able to reduce overall occurrences among humans, it has been demonstrated that the compound can reduce the amount of insulin a patient requires to reach target blood sugar levels and functionality.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.